InsidersTradesSigma
Browse the complete record of transactions filed by Sebaaly Camille, Chief Financial Officer. Insider active across 1 company, notably Sunshine Biopharma, Inc. In total, 1 reports have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €28k. Activity tracked since 3 June 2022. The latest transaction was disclosed on 3 June 2022 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
1 of 1 declaration
Camille Sebaaly is the Chief Financial Officer and Secretary of Sunshine Biopharma, Inc., a biopharmaceutical company. In her role, she oversees financial operations and governance matters. Camille brings expertise in finance and business management, contributing to Sunshine's growth strategy.